Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 104 Projects
Project # Contact PI Funding Organization Fiscal Year
Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's disease
ADDF-54 Alzheimer's Drug Discovery Foundation 2022
Clinical Implementation of Blood-Based Biomarkers for Alzheimer’s Disease: Clinical Validation, IVD Product Development, and Market Development
ADDF-55 Alzheimer's Drug Discovery Foundation 2022
Identifying a Patient-Specified Core Digital Measures Set in Alzheimer’s Disease and Related Dementias
ADDF-56 Alzheimer's Drug Discovery Foundation 2022
Validation of the Retinal Deep Phenotyping (TM) platform for the detection of the likely cerebral amyloid status to aid in the diagnosis of Alzheimer's disease
ADDF-31 Alzheimer's Drug Discovery Foundation 2021
Measurement of immune cell recruitment as a biomarker of neuroinflammation in Alzheimer's disease and other diseases of the central nervous system
ADDF-32 Alzheimer's Drug Discovery Foundation 2021
Plasma pathologic TDP-43 as a biomarker for FTLD-TDP
ADDF-36 Alzheimer's Drug Discovery Foundation 2021
Easy and early plasma pTau181 detection with LUMIPULSE G platform as indicator of Alzheimer's disease
ADDF-38 Alzheimer's Drug Discovery Foundation 2021
Validation and commercialization of a novel blood-based, ultra-multiplex Laboratory Developed Test (LDT) for the prediction of cerebral amyloid status before clinical onset of dementia
ADDF-41 Alzheimer's Drug Discovery Foundation 2021
Plasma neuroinflammatory biomarkers for the diagnossi of dementia subtypes
ADDF-42 Pase, Matthew Alzheimer's Drug Discovery Foundation 2021
Fixational eye motion as biomarker for mild cognitive impairment
ADDF-45 Alzheimer's Drug Discovery Foundation 2021